The European Cancer Congress 2015

login
My congress planner
close
Forgot password

Create account

Searchable Programme for ECC2015

Keyword / Author:
  • 26
    SAT
    16:45 – 18:15
    Innovations in Radiation Oncology

    Scientific Symposium: New Trends in Molecular Targeting for Radiation Oncology

    Chair: Y. Shiloh (Israel)

    Co-Chair: B. Wouters (Canada)

    16:45
    Immunotherapy and radiation therapy
    Speaker: E. Deutsch (France)
    Display Presentation Details

    17:05
    The link between receptors and signalling pathways and radiation therapy
    Speaker: K. Harrington (United Kingdom)

    17:25
    Angiogenesis and tumour vasculature influences radiation effects
    Speaker: M. Pruschy (Switzerland)
    Display Presentation Details

    17:45
    Why DNA repair is so important for radiation oncologists
    Speaker: T. Helleday (Sweden)

    Discussion & Roundup

  • 27
    SUN
    08:00 – 08:45
    Innovations in Radiation Oncology

    Teaching Lecture: Technical Innovations in Radiotherapy

    Chair: D. Verellen (Belgium)

    Speaker: C. Grau (Denmark)
    Display Presentation Details

  • 27
    SUN
    09:15 – 11:05
    Abstract nr
    Innovations in Radiation Oncology

    Proffered Paper Session: Innovations in Radiation Oncology

    Chair: D. Zips (Germany)

    Chair: B. Wouters (Canada)

    09:15
    600
    Utilisation of radiotherapy in Norway after the implementation of the National cancer plan – a prospective, national registry-based study
    Speaker: L.M. Åsli (Norway)
    Display abstract

    09:30
    601
    Towards automatic prediction of tumour growth from CT images using machine learning algorithms – a feasibility study
    Speaker: F. Guest (United Kingdom)
    Display abstract

    09:45
    602
    15O-H2O PET/CT confirms early postradiotherapy changes of heart perfusion in breast carcinoma patients
    Speaker: A. Zyromska (Poland)
    Display abstract

    10:00
    Discussant : E. Deutsch (France)

    10:10
    603
    Safety assessment of radiotherapy associated to targeted therapies in metastatic renal-cell carcinoma
    Speaker: R. Rivoirard (France)
    Display abstract

    10:25
    604
    Loss or therapeutic inhibition of extracellular adenosine production by ecto-5′-nucleotidase(CD73) attenuates radiation-induced lung fibrosis
    Speaker: V. Jendrossek (Germany)
    Display abstract

    10:40
    605
    Nintedanib safely reduces radiation-induced lung damage in a mouse model of partial lung irradiation
    Speaker: D. De Ruysscher (Belgium)
    Display abstract

    10:55
    Discussant : M. Verheij (Netherlands)

  • 27
    SUN
    11:30 – 12:30
    Innovations in Radiation Oncology

    Special Session: Translating Innovations in Functional Imaging into Clinical Trials

    Chair: F. Giammarile (France)

    11:30
    Biological and clinical rationale of the use of functional imaging
    Speaker: H. Lyng (Norway)
    Display Presentation Details

    11:40
    How to apply functional imaging in the radiation oncology clinic
    Speaker: L. Mortensen (Denmark)

    11:50
    From image to dose prescription and back
    Speaker: W. van Elmpt (Netherlands)
    Display Presentation Details

    Discussion

  • 27
    SUN
    13:00 – 14:30
    Innovations in Radiation Oncology

    Special Session: The Global Task Force on Radiotherapy for Cancer Control: A Lancet Oncology Commission

    Chair: D. Jaffray (Canada)

    13:00
    Challenges in cancer control in 2035
    Speaker: M. Gospodarowicz (Canada)

    13:15
    The equity gap in access to radiotherapy
    Speaker: Y. Lievens (Belgium)

    13:35
    An investment framework for global radiotherapy
    Speaker: R. Atun (United Kingdom)

    13:55
    Disruptive approaches – beyond investment
    Speaker: D. Jaffray (Canada)

    Panel discussion

    Chair: M. Baumann (Germany)

    Panel: R. Sullivan (United Kingdom)

    Panel: D. Collingridge (United Kingdom)

    Panel: R. Atun (United Kingdom)

    Panel: D. Jaffray (Canada)

    Panel: N. Enwerem-Bromson (Austria)

    Panel: E. Zubizarreta (Austria)

    Panel: J. Torode (Switzerland)

Print all results list